These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2645432)

  • 1. Does hyperuricosuria play a role in calcium oxalate lithiasis?
    Ettinger B
    J Urol; 1989 Mar; 141(3 Pt 2):738-41. PubMed ID: 2645432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hyperuricosuric calcium oxalate stone former.
    Sarig S
    Miner Electrolyte Metab; 1987; 13(4):251-6. PubMed ID: 3306317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of allopurinol treatment on the prevention of hyperuricosuric calcium oxalate lithiasis.
    Hofbauer J; Zechner O
    Eur Urol; 1988; 15(3-4):227-9. PubMed ID: 3215256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of calcium oxalate crystal growth in urine during treatment with allopurinol.
    Tiselius HG
    Br J Urol; 1980 Jun; 52(3):189-92. PubMed ID: 7426978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of recurrent uric acid and calcium oxalate stones by administration of the xanthine oxidase inhibitors Milurit 100 and Milurit 300.
    Schneider HJ; Brundig P; Balogh A; Traeger A; Stein G; Fünfstück R
    Int Urol Nephrol; 1983; 15(2):121-9. PubMed ID: 6688800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [When does allopurinol treatment fail in recurring calcium lithiasis?].
    Ulshöfer B; Kiechle J
    Helv Chir Acta; 1985 Sep; 52(3-4):499-502. PubMed ID: 4066382
    [No Abstract]   [Full Text] [Related]  

  • 8. Nucleation kinetics in the calcium oxalate-sodium urate monohydrate system.
    Meyer JL
    Invest Urol; 1981 Nov; 19(3):197-201. PubMed ID: 7298292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperuricosuria and urolithiasis].
    Koide T
    Nihon Rinsho; 1996 Dec; 54(12):3273-6. PubMed ID: 8976104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol in the recurrence prevention of calcium oxalate lithiasis.
    Brien G; Bick C
    Eur Urol; 1977; 3(1):35-6. PubMed ID: 837952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic treatment of uric acid calculi.
    Preminger GM
    Urol Clin North Am; 1987 May; 14(2):335-8. PubMed ID: 3576854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of allopurinol in the prevention of calcium oxalate calculi.
    Ettinger B; Tang A; Citron JT; Livermore B; Williams T
    N Engl J Med; 1986 Nov; 315(22):1386-9. PubMed ID: 3534570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oxalate: its role in lithogenesis and composition of calcium oxalate lithiasis].
    Fernandez Rodríguez A; Arrabal Martín M; Domínguez Molinero JF; Mijan Ortiz JL; Sánchez Tamayo J; Zuluaga Gómez A
    Actas Urol Esp; 1995 Sep; 19(8):620-6. PubMed ID: 8669329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The experimental and clinical studies on the urinary calculi with the special reference to the metabolism of uric acid. Report II: relationship between urinary uric acid excretion and recurrent urinary oxalate containing calculus formation with special reference to the prevention of recurrence of formation (author's transl)].
    Kawamura T
    Nihon Hinyokika Gakkai Zasshi; 1975 Oct; 66(10):661-71. PubMed ID: 1240543
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperuricosuric calcium nephrolithiasis.
    Sorensen CM; Chandhoke PS
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):915-25. PubMed ID: 12474638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of effect of allopurinol on oxalate excretion by stone patients on random and controlled diets.
    Urivetzky M; Braverman S; Motola JA; Smith AD
    J Urol; 1990 Jul; 144(1):97-8. PubMed ID: 2359187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():265-71. PubMed ID: 6938003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones.
    Kohri K; Kodama M; Katayama Y; Ishikawa Y; Takada M; Kataoka K; Katoh Y; Iguchi M; Kurita T
    Urology; 1990 Oct; 36(4):309-14. PubMed ID: 2219608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.
    Arowojolu O; Goldfarb DS
    J Nephrol; 2014 Dec; 27(6):601-5. PubMed ID: 24687403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An architectural study of mixed uric acid and calcium oxalate stones by polarized light microscopy of thin section].
    Takeuchi H; Arai Y; Konishi T; Tomoyoshi T
    Hinyokika Kiyo; 1988 Sep; 34(9):1529-35. PubMed ID: 3213788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.